1. Home
  2. LPCN vs ELSE Comparison

LPCN vs ELSE Comparison

Compare LPCN & ELSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LPCN
  • ELSE
  • Stock Information
  • Founded
  • LPCN 1997
  • ELSE 1968
  • Country
  • LPCN United States
  • ELSE United States
  • Employees
  • LPCN N/A
  • ELSE N/A
  • Industry
  • LPCN Biotechnology: Pharmaceutical Preparations
  • ELSE Industrial Machinery/Components
  • Sector
  • LPCN Health Care
  • ELSE Industrials
  • Exchange
  • LPCN Nasdaq
  • ELSE Nasdaq
  • Market Cap
  • LPCN 16.1M
  • ELSE 13.2M
  • IPO Year
  • LPCN N/A
  • ELSE N/A
  • Fundamental
  • Price
  • LPCN $3.17
  • ELSE $4.26
  • Analyst Decision
  • LPCN Strong Buy
  • ELSE
  • Analyst Count
  • LPCN 2
  • ELSE 0
  • Target Price
  • LPCN $9.00
  • ELSE N/A
  • AVG Volume (30 Days)
  • LPCN 71.7K
  • ELSE 79.4K
  • Earning Date
  • LPCN 05-08-2025
  • ELSE 05-12-2025
  • Dividend Yield
  • LPCN N/A
  • ELSE N/A
  • EPS Growth
  • LPCN N/A
  • ELSE 14.32
  • EPS
  • LPCN N/A
  • ELSE 0.11
  • Revenue
  • LPCN $3,674,834.00
  • ELSE $9,368,000.00
  • Revenue This Year
  • LPCN N/A
  • ELSE N/A
  • Revenue Next Year
  • LPCN N/A
  • ELSE N/A
  • P/E Ratio
  • LPCN N/A
  • ELSE $40.45
  • Revenue Growth
  • LPCN N/A
  • ELSE 7.01
  • 52 Week Low
  • LPCN $2.68
  • ELSE $3.65
  • 52 Week High
  • LPCN $11.79
  • ELSE $5.50
  • Technical
  • Relative Strength Index (RSI)
  • LPCN 43.78
  • ELSE 53.93
  • Support Level
  • LPCN $3.00
  • ELSE $4.01
  • Resistance Level
  • LPCN $3.49
  • ELSE $4.32
  • Average True Range (ATR)
  • LPCN 0.34
  • ELSE 0.17
  • MACD
  • LPCN -0.05
  • ELSE 0.04
  • Stochastic Oscillator
  • LPCN 16.50
  • ELSE 79.02

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

About ELSE Electro-Sensors Inc.

Electro-Sensors Inc manufactures and sells industrial production monitoring and process control systems. It manufactures a complete line of monitoring and control systems for a wide range of industrial machine applications. The systems measure machine production and operation rates, as well as regulate the speed of related machines in production processes. Its products include motor drive control, position monitors, sensor targets, signal conditioners, speed sensors, speed switches, tachometers, temperature sensors, vibration monitors, etc.

Share on Social Networks: